Overview

* Alignment Healthcare ( ALHC ) Q2 revenue rises 49% yr/yr, beating analyst expectations

* Adjusted EBITDA for Q2 beats consensus, reflecting robust operational performance

* Co raises full-year outlook across membership, revenue, adjusted gross profit, EBITDA

Outlook

* Company raises full-year outlook for membership, revenue, adjusted gross profit, EBITDA

* Company expects Q3 revenue between $970 mln and $985 mln

* Alignment Healthcare ( ALHC ) projects full-year revenue between $3.885 bln and $3.910 bln

* Company anticipates Q3 adjusted EBITDA between $5 mln and $13 mln

Result Drivers

* MEMBERSHIP GROWTH - Health plan membership increased by 27.8% yr/yr, reaching 223,700 members

* REVENUE INCREASE - Total revenue rose 49% yr/yr to $1.015 bln, surpassing analyst expectations

* MEDICARE ADVANTAGE MODEL - Co attributes strong Q2 performance to its Medicare Advantage model focusing on clinical excellence and affordability

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $1.02 $960.30

Revenue bln mln (10

Analysts

)

Q2 Net $15.65

Income mln

Q2 Beat $45.91 $15.80

Adjusted mln mln (10

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the managed healthcare peer group is "buy"

* Wall Street's median 12-month price target for Alignment Healthcare Inc ( ALHC ) is $20.00, about 41.1% above its July 29 closing price of $11.78

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)